Two-Stage Blood Glucose Prediction Using Pre-Training

The EPO published patent application EP2024060438A1 for a two-stage blood glucose prediction method incorporating machine learning pre-training and data decomposition. The application is classified under IPC G06N 20/00 (machine learning) along with medical informatics (G16H 50/50) and blood glucose measurement (A61B 5/145). Designated states include all EU member states and extended states.

For applicants and technology companies, this publication establishes a public record of the invention and its technical claims. Third parties have six months from publication to file observations under Article 115 EPC. The patent application does not impose compliance obligations on other parties beyond standard patent publication procedures.